Home / Import refusals / 1FX-0135731-8/30002/2

FDA Import Refusal 1FX-0135731-8/30002/2 — CAPLIN POINT

CAPLIN POINT — FEI 3023419653

The FDA refused shipment 1FX-0135731-8/30002/2 from CAPLIN POINT (Guatemala) on June 12, 2026. The refused product falls under Drugs and Biologics — IBUPROFEN (ANTI-INFLAMMATORY). Cited charge: 75 This firm has 5 or more other import refusals on record.

Refusal Details

Date
June 12, 2026
Country
Guatemala
Product Category
Drugs and Biologics
Product Code
62GCA41 IBUPROFEN (ANTI-INFLAMMATORY)
Charges
75

Other import refusals

  • 1FX-4666446-1/60002/1 (Wed Jul 01 2026 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • 1FX-4666446-1/50002/1 (Wed Jul 01 2026 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • AEK-9331533-9/30003/1 (Fri Mar 06 2026 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • AEK-9331533-9/20003/1 (Fri Mar 06 2026 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • AEK-9433073-3/10002/1 (Fri Feb 20 2026 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)

FDA data resources